Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions
Authors
Keywords
-
Journal
OncoImmunology
Volume 2, Issue 9, Pages e25994
Publisher
Informa UK Limited
Online
2013-10-04
DOI
10.4161/onci.25994
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of a Soluble TGF- Receptor by Tumor Cells Enhances Dendritic Cell/Tumor Fusion Vaccine Efficacy
- (2014) M. Zhang et al. JOURNAL OF IMMUNOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes
- (2013) Shigeo Koido et al. PLoS One
- Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-β1 Blockade and IL-12p70 Production
- (2013) Shigeo Koido et al. PLoS One
- Fusions between dendritic cells and whole tumor cells as anticancer vaccines
- (2013) Shigeo Koido et al. OncoImmunology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells
- (2011) Helen Conroy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cooperative Regulation of NOTCH1 Protein-Phosphatidylinositol 3-Kinase (PI3K) Signaling by NOD1, NOD2, and TLR2 Receptors Renders Enhanced Refractoriness to Transforming Growth Factor-β (TGF-β)- or Cytotoxic T-lymphocyte Antigen 4 (CTLA-4)-mediated Impairment of Human Dendritic Cell Maturation
- (2011) Devram Sampat Ghorpade et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Vaccine by Fusions of Dendritic and Cancer Cells
- (2010) Shigeo Koido et al. Clinical & Developmental Immunology
- Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions
- (2010) Shigeo Koido et al. Clinical & Developmental Immunology
- Systemic Inhibition of Transforming Growth Factor- in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
- (2009) R. Ueda et al. CLINICAL CANCER RESEARCH
- Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor- Monoclonal Antibody
- (2009) M. Terabe et al. CLINICAL CANCER RESEARCH
- Cancer immunotherapy by fusions of dendritic cells and tumor cells
- (2009) Shigeo Koido et al. Immunotherapy
- A Heat Shock Protein 70-Based Vaccine with Enhanced Immunogenicity for Clinical Use
- (2009) Jianlin Gong et al. JOURNAL OF IMMUNOLOGY
- Paired Toll-like Receptor Agonists Enhance Vaccine Therapy through Induction of Interleukin-12
- (2008) R. Zheng et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started